Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 4780 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 6971 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 7097 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 9228 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 25866 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 25971 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 29450 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 30603 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 34310 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 37278 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 40221 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 40821 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 43629 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 44373 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 54827 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 56466 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 58815 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M-H)- | 59444 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 38234 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 42594 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 48861 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 52583 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 53681 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 57707 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 57787 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 59850 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 60435 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 66138 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 67264 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 72703 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 79175 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 79586 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 83932 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 85565 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | 91532 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | AZELAIC ACID (CAS# 123-99-9); (M+NA)+ | Peak area | Severe disease |